Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. we hope you enjoy reading it.

1. The Central Consumer Protection Authority (CCPA) has directed all e-commerce platforms to conduct self-audits within three months to eliminate ‘dark patterns’. Platforms are encouraged to submit self-declarations affirming compliance with the 2023 Guidelines for Prevention and Regulation of Dark Patterns.
Source: bit.ly/43SkWPg

2. Indian Government is reportedly planning to introduce a Minimum Import Price (MIP) on pharmaceutical raw materials including Key Starting Materials (KSMs), drug intermediates, and Active Pharmaceutical Ingredients (APIs) to curb the influx of low-cost Chinese imports and support domestic manufacturers.
Source: bit.ly/3Tjvdz6

3. The Ministry of Agriculture and Farmers Welfare has notified the draft Insecticides (Amendment) Rules, 2025, aimed at simplifying licences for insecticides used for household purposes. The amendments reduce application timelines from 90 to 30 days, mandate QR codes on retail packs, and applicants applying for renewal must now meet the educational qualification requirement and require applicants renewing their licences to meet the prescribed educational qualifications.
Source: bit.ly/43PCD23

4. India’s National Consumer Disputes Redressal Commission upheld LIC’s appeal, affirming that insurance contracts require utmost good faith (uberrimae fidei) and placing the burden of disclosure on the insured. Citing the insured’s failure to disclose a prior medical condition as material, it found the State Commission’s award flawed and ordered a fresh review.
Source: bit.ly/3SHoBKU

5. India’s Ministry of Finance has revised several General Financial Rules (GFRs) to ease and expedite procurement processes for scientific equipment and consumables in government-funded research and S&T institutions, by raising financial limits for direct purchases and tenders by head of institutes.
Source: bit.ly/3Zlo8lo

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Reader, We are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

Panel of auditors to audit the promotional expenses of pharma and medical device companies will be appointed soon: Government
The Secretary, Department of Pharmaceuticals, has reportedly said that the government will appoint a panel of auditors who can undertake risk-based audits from time to time, to evaluate whether the promotional expenses, especially towards conferences and workshops, have been incurred in an ethical manner as per the Uniform Code for Pharmaceutical Marketing Practices 2024. Any discrepancy will be reported to the appropriate government agency or authority.
Source: bit.ly/49SNs5f

Industry welcomes the new Uniform Code for Pharmaceutical Marketing Practices
The pharmaceutical industry has reportedly welcomed the new Uniform Code for Pharmaceutical Marketing Practices (UCPMP). According to news reports, the industry feels that the new code is a step ahead towards the advancement of the industry as it ensures ethical and healthy engagement between the pharmaceutical industry and medical professionals.
Source: bit.ly/4a6SZWd

Nutraceutical and food supplement regulations are to be tightened further
The Food Safety and Standards Authority of India (FSSAI) is in the process of tightening the regulations for nutraceuticals and health supplements. This move was prompted by the receipt of several complaints by the FSSAI about the presence of non-compliant health supplements on the market and the fact that the over-the-counter availability of nutraceuticals and health supplements is resulting in people consuming supplements along with drugs, which increases the risk of adverse effects.
Source: bit.ly/3wXMsOU

A major e-commerce entity was fined Rs 25 lakh due to its inaction to remove counterfeit products from the marketplace
A State Consumer Commission in India has imposed a fine of Rs. 25 lakhs on a major e-commerce entity on the grounds that the e-commerce entity failed to correct the listing of a product, which it was aware was a counterfeit product. By failing to remove the listing, the Commission held that the e-commerce entity had engaged in dark patterns and unjust enrichment.
Source: bit.ly/3IBUsaH

EU to extend regulatory data protection for innovator drugs to 7.5 years
The European Union is set to extend regulatory data protection for innovator drugs to 7.5 years, with one extra year of incentives if the drug meets an unmet medical need and clinical trials are conducted in the EU. There is a proposal to grant an additional 3 years of protection from generics, taking the total protection to a maximum of 11.5 years.
Source: bit.ly/3IxEIWl